37 citations,
May 2003 in “Journal of Consumer Marketing”
The debate on direct-to-consumer pharmaceutical ads continues, with consumers finding them educational and doctors concerned about their impact on patient relationships and medication understanding.
The post discusses a theory that hair regrowth after transplant is due to the angiogenesis process (new blood vessels forming), not because the transplanted hair is unaffected by DHT. The responses highlight the established belief in 'donor dominance' (the importance of the hair's origin in transplantation) and skepticism about the new theory.
Dutasteride is more effective than finasteride, has neuroprotective benefits, and may prevent acne. Despite initial concerns about metabolic effects, further research suggests it is safe for most users, especially if not hypogonadal.
The conversation discusses hair loss treatments, specifically mentioning Minoxidil, finasteride, and RU58841. It highlights a study suggesting that sulforaphane may reduce DHT levels and promote hair growth in mice.
The user started using minoxidil in March 2024, added dermastamping, and later switched to a minoxidil/finasteride spray, also using Nizoral. They report fuller hair and positive comments from friends and family.
A young man in his mid-20s started using finasteride and biotin for hair thinning and has seen less hair loss after three months. Others shared their positive experiences with minoxidil and finasteride, discussed potential side effects, and encouraged early treatment for hair loss.